The Economic Burden of Systemic Lupus Erythematosus in Commercially- and Medicaid-insured Populations in the United States

OBJECTIVE: To estimate the economic burden of systematic lupus erythematous (SLE), stratified by disease severity, in commercially- and Medicaid-insured US populations METHODS: Adults (≥18 years) with SLE treated with antimalarials, selected biologics, immunosuppressants, and systemic glucocorticoid...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Semin Arthritis Rheum
Egile Nagusiak: Clarke, Ann E., Yazdany, Jinoos, Kabadi, Shaum M., Durden, Emily, Winer, Isabelle, Griffing, A. Kirstin, Costenbader, Karen H.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7857313/
https://ncbi.nlm.nih.gov/pubmed/32531505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.semarthrit.2020.04.014
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak